Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00256620 · ClinicalTrials.gov registry record · NA

Improving Outcomes and Quality of Life After CABG

A NA study of Coronary Artery Bypass Graft Surgery Patients, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
412
Enrollment target
1
Study location

NCT00256620 is a NA study of Coronary Artery Bypass Graft Surgery Patients that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 412 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00256620, a NA study of Coronary Artery Bypass Graft Surgery Patients, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
412 participants
Enrollment target
1
Study location

Study Summary

The principal objective to this randomized trial is to compare the efficacy of two strategies of intra-operative hemodynamic management during cardiopulmonary bypass among patients undergoing primary elective coronary artery bypass graft (CABG) surgery in preventing peri-operative cardiac, cognitive and neurologic morbidity and mortality and post-operative deterioration in the patient's quality of life as measured by the seven domains of SF-36 Health Survey (bodily pain, health perceptions, energy, and mental, physical, social and role function).

Interventions

  • PROCEDURE Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized

Study Locations (1)

New York

  • New York Presbyterian Hospital-Weill Medical Center - New York

Trial Details

FieldValue
Enrollment Target 412 participants
Start Date 1996-12
Est. Completion 1999-12
Phase NA

What the Registry Record Tells You About NCT00256620

The ClinicalTrials.gov registry entry for NCT00256620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 412 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Bypass Graft Surgery Patients appearing as the primary indexed condition, and to 1 intervention - of which Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized is the first listed.

NCT00256620 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00256620 about?

NCT00256620 is a clinical study titled "Improving Outcomes and Quality of Life After CABG". The principal objective to this randomized trial is to compare the efficacy of two strategies of intra-operative hemodynamic management during cardiopulmonary bypass among patients undergoing primary elective coronary artery bypass graft (CABG) surgery in preventing peri-operative cardiac, cognitive...

What is the current status of trial NCT00256620?

This trial is currently completed. It is a NA study. The enrollment target is 412 participants. The study started on 1996-12. Estimated completion is 1999-12.

What conditions does trial NCT00256620 study?

This clinical trial studies the following conditions: Coronary Artery Bypass Graft Surgery Patients.

What interventions are being tested in trial NCT00256620?

The interventions under investigation include: Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized (PROCEDURE).

Who is sponsoring clinical trial NCT00256620?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00256620 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.